J Askling

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?
    J Askling
    Karolinska Institute, Stockholm, Sweden
    Ann Intern Med 131:655-9. 1999
  2. ncbi Increased risk for cancer following sarcoidosis
    J Askling
    Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
    Am J Respir Crit Care Med 160:1668-72. 1999
  3. pmc Risk of non-Hodgkin's lymphoma following tuberculosis
    J Askling
    Department of Medical Epidemiology, Karolinska Institute, Box 281, Stockholm, S 171 77, Sweden
    Br J Cancer 84:113-5. 2001
  4. ncbi Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study
    J Askling
    Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
    Lancet 357:262-6. 2001
  5. ncbi Family history as a risk factor for colorectal cancer in inflammatory bowel disease
    J Askling
    Department of Medical Epidemiology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
    Gastroenterology 120:1356-62. 2001
  6. pmc Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
    J Askling
    Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
    Ann Rheum Dis 64:1414-20. 2005
  7. doi Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
    J Askling
    Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden
    Ann Rheum Dis 68:648-53. 2009
  8. doi Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
    M Neovius
    Department of Medicine, Karolinska Institutet, SE 171 76 Stockholm, Sweden
    Ann Rheum Dis 70:516-9. 2011
  9. doi Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice
    M Neovius
    Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Ann Rheum Dis 70:1407-14. 2011
  10. pmc Swedish registers to examine drug safety and clinical issues in RA
    J Askling
    Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden
    Ann Rheum Dis 65:707-12. 2006

Collaborators

Detail Information

Publications25

  1. ncbi Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?
    J Askling
    Karolinska Institute, Stockholm, Sweden
    Ann Intern Med 131:655-9. 1999
    ..Nonmelanoma skin cancer is associated with increased occurrence of subsequent cancer and death from cancer, but it is not known whether a history of skin cancer is associated with poor prognosis after a second diagnosis of cancer...
  2. ncbi Increased risk for cancer following sarcoidosis
    J Askling
    Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
    Am J Respir Crit Care Med 160:1668-72. 1999
    ..4; 95% CI 0.8 to 2.2). Thus, sarcoidosis appears to be associated with a significantly increased risk for cancer in affected organs. Chronic inflammation is a putative mediator of this risk...
  3. pmc Risk of non-Hodgkin's lymphoma following tuberculosis
    J Askling
    Department of Medical Epidemiology, Karolinska Institute, Box 281, Stockholm, S 171 77, Sweden
    Br J Cancer 84:113-5. 2001
    ..The overall relative risk was moderately increased, largely accounted for by high risks following severe tuberculosis diagnosed a long time ago...
  4. ncbi Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study
    J Askling
    Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
    Lancet 357:262-6. 2001
    ..We aimed to assess cancer rates among first-degree relatives of patients with IBD to try to determine whether an association between the two diseases exists...
  5. ncbi Family history as a risk factor for colorectal cancer in inflammatory bowel disease
    J Askling
    Department of Medical Epidemiology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
    Gastroenterology 120:1356-62. 2001
    ..Little is known about the cancer risk in familial inflammatory bowel disease (IBD). We assessed the significance of familial CRC, or IBD, on the risk for CRC in patients with IBD...
  6. pmc Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
    J Askling
    Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
    Ann Rheum Dis 64:1414-20. 2005
    ..Patients with rheumatoid arthritis (RA) are at increased risk of malignant lymphomas, and maybe also of leukaemia and multiple myeloma. The effect of tumour necrosis factor (TNF) antagonists on lymphoma risk and characteristics is unclear...
  7. doi Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
    J Askling
    Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden
    Ann Rheum Dis 68:648-53. 2009
    ....
  8. doi Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
    M Neovius
    Department of Medicine, Karolinska Institutet, SE 171 76 Stockholm, Sweden
    Ann Rheum Dis 70:516-9. 2011
    ..To determine coverage and generalisability of data in the Swedish Biologics Register ARTIS...
  9. doi Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice
    M Neovius
    Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Ann Rheum Dis 70:1407-14. 2011
    ..To investigate sick leave and disability pension in rheumatoid arthritis (RA) in relation to the initiation of biological and non-biological antirheumatic therapies in clinical practice...
  10. pmc Swedish registers to examine drug safety and clinical issues in RA
    J Askling
    Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden
    Ann Rheum Dis 65:707-12. 2006
    ..The approach described is a possible prototype for long term surveillance systems needed for the safe introduction of new treatments...
  11. pmc Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis
    L Björnådal
    Rheumatology Unit, Department of Medicine, Karolinska University Hospital Solna, and Karolinska Institutet, Stockholm, Sweden
    Ann Rheum Dis 65:741-5. 2006
    ..However, little is known about whether or to what extent hereditary factors for CVD contribute additional risk in patients with rheumatoid arthritis...
  12. doi Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study
    J F Simard
    Karolinska Institutet, Stockholm, Sweden
    Arthritis Rheum 62:3776-82. 2010
    ..Therefore, the aim of this study was to determine the risk of cancer in patients with JIA as compared with that in the general population...
  13. doi Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study
    M Elmberg
    Division of Gastroenterology and Hepatology, Karolinska University Hospital Clinical, Stockholm, Sweden
    J Intern Med 272:45-54. 2012
    ..Little is known of these risks among heterozygotes also being first-degree relatives (FDRs), thus sharing other factors for phenotypic expression of GH...
  14. pmc Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study
    J Askling
    Department of Medicine, Clinical Epidemiology Unit M9 01, Karolinska University Hospital Solna, SE 171 77, Stockholm, Sweden
    Ann Rheum Dis 65:1184-7. 2006
    ..Besides inflammation-lymphoma aetiology, information on risk of lymphoma in ankylosing spondylitis is particularly important as a benchmark in the evaluation of, for example, tumour necrosis factor inhibitors...
  15. pmc Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma
    K E Smedby
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, SE 171 77 Stockholm, Sweden
    Gut 54:54-9. 2005
    ..A systematic risk assessment of more prevalent lymphoma entities, such as B cell and non-intestinal lymphomas, in coeliac disease has not been performed...
  16. doi Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009
    M Neovius
    Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm
    Scand J Rheumatol 40:8-15. 2011
    ..To measure small-area variations in sales per capita of tumour necrosis factor (TNF) inhibitors...
  17. ncbi Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden
    K Hellgren
    Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden
    Arthritis Rheumatol 66:1282-90. 2014
    ..This study was undertaken to assess the risk of lymphoma in AS and PsA overall and in relation to therapies, including tumor necrosis factor inhibitor (TNFi), for which lymphoma risks are a concern...
  18. doi Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update
    K E Smedby
    Department of Medicine, Clinical Epidemiology Unit, Karolinska University Hospital, Stockholm, Sweden
    J Intern Med 264:514-27. 2008
    ..Future studies of high-risk patient subsets using detailed assessments of autoimmunity/inflammation and lymphoma may give important clues to lymphomagenesis...
  19. doi The risk of malignancies in RA patients treated with biologics
    J Askling
    Clinical Epidemiology Unit T2 01, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital Solna, 171 76, Stockholm, Schweden
    Z Rheumatol 69:774-9. 2010
    ..So far, but with exceptions both in terms of risks observed and absence of data, the emerging picture is reassuring rather than alarming...
  20. doi Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006
    M E Holmqvist
    Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
    J Intern Med 268:578-85. 2010
    ..Few studies have included contemporary patients with RA. We recently reported that the risk of IHD is not elevated before the onset of RA symptoms. However, when, in relation to RA diagnosis, the risk is increased is unknown...
  21. doi Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis
    C Carlens
    Department of Medicine, Karolinska University Hospital and Institute, Stockholm, Sweden
    Ann Rheum Dis 68:1159-64. 2009
    ..To investigate the importance of birth characteristics and early life infections on the risk of later rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA)...
  22. ncbi Rheumatoid arthritis registries in Sweden
    R F van Vollenhoven
    Rheumatology Unit, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden
    Clin Exp Rheumatol 23:S195-200. 2005
    ..Data obtained from analyses based on these registries are reviewed. It is concluded that rheumatology registries are excellent tools for improving our knowledge base regarding rheumatic diseases...
  23. pmc Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001
    H Hildebrand
    Department of Women and Child Health, Astrid Lindgren Children s Hospital, Stockholm, Sweden
    Gut 52:1432-4. 2003
    ..An increased incidence of paediatric Crohn's disease was reported recently by our group...
  24. doi Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study
    K Busch
    Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Aliment Pharmacol Ther 39:57-68. 2014
    ..Regional studies on inflammatory bowel disease (IBD) suggest an increasing prevalence over time, but no nationwide estimate has been published so far...
  25. pmc Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
    J Askling
    Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
    Ann Rheum Dis 64:1421-6. 2005
    ..Existing studies of solid cancers in rheumatoid arthritis (RA) reflect cancer morbidity up until the early 1990s in prevalent cohorts admitted to hospital during the 1980s...